Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan
Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study is being performed to test if the use of high dose of cetuximab in combination
with irinotecan overcomes the resistance seen with standard dose of cetuximab plus irinotecan
in patients with wild type KRS tumors that have advanced colon or rectal cancer